SEC Tracker
Get the app

biote BTMD

Biote Corp., commenced (i) its offer to each holder of its outstanding warrants

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Changes shareholder rights (3.03)
  • Reports shareholder vote results (5.07)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when biote files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.

  1. Assembly Biosciences ASMB public float $98M, Jun 30, 2025
  2. Milestone Pharmaceuticals MIST public float $99M, Jun 30, 2025
  3. DiaMedica Therapeutics DMAC public float $96M, Jun 30, 2025
  4. Carisma Therapeutics CARM
  5. Larimar Therapeutics LRMR public float $95M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.